Zymergen Raises $130M
Emeryville-based Zymergen, a startup that is tying together data science, automation, and biology for the chemical and materials, agriculture, and healthcare market, has raised $130M in a Series B funding. The funding was led by SoftBank Group, and also included Data Collective, True Ventures, AME Cloud Ventures, DFJ, Innovation Endeavors, Obvious Ventures, and Two Sigma Ventures, plus Iconiq Capital, Prelude Ventures, and Tao Capital Partners. The company has appointed former U.S. Secretary of Energy and Nobel laureate Dr. Steven Chu, and SoftBank Group International Managing Director Deep Nishar to its board as part of the funding. Zymergen's co-founder and CEO is Joshua Hoffman.
posted on Tuesday, October 11, 2016 (Link to more information)
Related companies:
Zymergen Inc.
Related stories:
> Bloom Energy Snags $130M More
> Katerra Gets $130M Funding Round
> SGN Finds $130M From South Korean Game Publisher Netmarble
> Barracuda Networks Lands $130M, Eyes IPO
> Redpoint Closes $130M Brazilian Investment Fund
silicontap.com Home